Atrial natriuretic peptide

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

ANF; Atrial natriuretic factor; Atrial natriuretic peptide, ANP; Atrial natriuretic peptides; Atriopeptin, natriuretic peptide type A, cardionatrine, CDD, cardiodilatin

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The Atrial Natriuretic Peptide belongs to the so-called "natriuretic peptides" of the heart (see also BNP, CNP). ANP ensures that sodium is excreted via the kidneys. ANP is an opponent of the blood pressure-increasing renin-angiotensin-aldosterone system. The peptide is mainly formed in cardiomyocytes (myocytes) of the atria when the atria of the heart are dilated and released into the blood. ANP is also produced by immune cells and performs functions in innate and adaptive immunity.

ANP is important for the body's water and salt balance and for blood pressure. It is the antagonist of the system in the body that causes blood pressure to rise, namely the so-called "renin-angiotensin-aldosterone system". ANP inhibits the release of renin (a hormone of the kidney that causes blood pressure to rise) and aldosterone (a hormone of the adrenal cortex that prevents sodium from being excreted through the kidney). It also has a vasodilating effect (vasodilatation). By activating membrane-bound guanyl cyclases, ANP induces an increase in intracellular cGMP concentration. cGMP activates the cGMP-dependent protein kinase (PRKG1), which activates ATP-dependent calcium pumps in the cell membrane through phosphorylation. Calcium ions are increasingly transported out of the cell. This leads to the relaxation of smooth muscles.

Note(s)This section has been translated automatically.

The ANP-encoding gene (ANP gene) codes for a 151 amino acid prepro-ANP. By splitting off an N-terminal signal peptide (25 amino acids), pro-ANP is formed. Corin, a membrane-bound serine protease, cleaves ANP from the C-terminal (28 amino acids) in a final step.

LiteratureThis section has been translated automatically.

  1. de Bold AJ et al (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sciences 28: 89-94.
  2. de Bold AJ (November 1985). Atrial natriuretic factor: a hormone produced by the heart". Science. 230: 767–770.
  3. Potter LR et al (2009) Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handbook of Experimental Pharmacology. cGMP: Generators, Effectors and Therapeutic Implications. 191st Springer Berlin Heidelberg. SS 341-366.
  4. Yan W et al (1999). Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. The Journal of Biological Chemistry. 274: 14926–1435.

Authors

Last updated on: 29.10.2020